Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
LB4330
i
Other names:
LB4330, Bis2, LB-4330, LB 4330, Bis-2, Bis 2
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
News
Trials
Company:
L&L Biopharma
Drug class:
CLDN18.2 inhibitor, CD8 T-cell agonist
Related drugs:
‹
zolbetuximab-clzb (11)
ZL-1211 (4)
TJ-CD4B (4)
AZD5863 (3)
AB011 (2)
ASP2138 (2)
TST001 (2)
MIL93 (1)
Q-1802 (1)
ASKB589 (0)
BNT141 (0)
DR30303 (0)
FL-301 (0)
IBI-389 (0)
IBI360 (0)
LM-102 (0)
PM1032 (0)
PM3023 (0)
PT886 (0)
QLS31905 (0)
SG1906 (0)
TAC101-Claudin18.2 (0)
AMG 910 (0)
ADP-A2M4CD8 (1)
AB248 (0)
AB821 (0)
EU204 (0)
Human tyrosinase DNA Vaccine (0)
IL-15 DC (0)
IMA203CD8 (0)
NEXI-001 (0)
NEXI-002 (0)
NEXI-003 (0)
SLC-3010 (0)
rhIL-15 (0)
zolbetuximab-clzb (11)
ZL-1211 (4)
TJ-CD4B (4)
AZD5863 (3)
AB011 (2)
ASP2138 (2)
TST001 (2)
MIL93 (1)
Q-1802 (1)
ASKB589 (0)
BNT141 (0)
DR30303 (0)
FL-301 (0)
IBI-389 (0)
IBI360 (0)
LM-102 (0)
PM1032 (0)
PM3023 (0)
PT886 (0)
QLS31905 (0)
SG1906 (0)
TAC101-Claudin18.2 (0)
AMG 910 (0)
ADP-A2M4CD8 (1)
AB248 (0)
AB821 (0)
EU204 (0)
Human tyrosinase DNA Vaccine (0)
IL-15 DC (0)
IMA203CD8 (0)
NEXI-001 (0)
NEXI-002 (0)
NEXI-003 (0)
SLC-3010 (0)
rhIL-15 (0)
›
Associations
News
Trials
VERI cancer hierarchy
Reset Filters
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login